StockData
4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc. (FDMT) stock

FDMTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3015% below fair value
$10.79−0.50 (-4.43%)

Close on Nov 17, 2026Market cap $778.82MP/E –Yield –

4D Molecular Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

4D Molecular Therapeutics's total debt was $19.59M at Jun 30, 2026. For fiscal 2025 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.59M–
Q4 FY2025Dec 31, 2025$0–

More 4D Molecular Therapeutics figures

See a number that looks wrong?